Early Stage researchers

Amir Far

(recruited by Maastricht University, Netherlands)

Amir was born in Israel and at the age of 21, he left to Italy where he successfully received his medical degree at the “Federico II” University of Naples.

He did his internship in the neurosurgery department and his postgraduation training in neurology. During his studies, he specifically focused on neuromuscular diseases.

Morena Shkodra

(recruited by Istituto Nazionale dei Tumori, Italy)

Morena was born in Durres, Albania. She received her medical degree from the University of Medicine, Tirana in 2016.

Currently she is working as an Early Stage Researcher at the National Cancer Institute Milan as part of the PAIN-Net project founded by EU Horizon 2020 Marie Skłodowska-Curie MSCA- ITN.

Mirna Andelic

(recruited by Fondazione IRCCS Istituto Neurologico Carlo Besta, Italy)

Mirna is an Early Stage Researcher currently working at Neurological Institute Carlo Besta in Milan, Italy, under supervision of prof. Giuseppe Lauria, MD, PhD. She holds master’s degree in Laboratory Medicine from Faculty of Medicine Osijek (Croatia) where she was co-founder and president of student’s association CMLDSA.

Her research objectives are to investigate morphometry and expression levels of pain-related ion channels in terminal cutaneous nociceptors.

Lenin Alejandro Reyes Haro

(recruited by Neuroscience Technologies, Spain)

Lenin is a Medical Doctor, with a Clinical Neurophysiologist specialization at the Latin American School of Medicine in Havana, Cuba. He is currently working as Early Stage Researcher (PAIN-Net Project) at Neuroscience Technologies in Barcelona, Spain, under supervision of Jordi Serra and Romà Solà.

His research objectives are to perform microneurographic recordings to quantify the excitability of different classes of nociceptors in peripheral neuropathic pain patients and healthy subjects, and to assess excitability and spontaneous activity of C-nociceptors to identify the key readouts that correspond to the experienced intensity of pain.

Federico Ponente

(recruited by Neuroscience Technologies, Spain)

Federico received the B.Sc. degree (Electronic Engineering) from the Polytechnic University of Turin in 2015, and the M.Sc. degree (Nanotechnologies for ICTs) from a joint program within Polytechnic University of Turin, Grenoble INP and École Polytechnique Féderale de Lausanne (EPFL) in 2017.

He worked as an Intern at the University of Oxford and he carried out his master thesis at Harvard University (Harvard Medical School). He is currently working at Neuroscience Technologies, as Early Stage Researcher (ESR) within the Pain-Net consortium. Meanwhile, he has started a Ph.D. in Biomedicine, research area of Neuroscience, at the University of Barcelona.

Milena Molasy

(recruited by Maastricht University, Netherlands)

Milena graduated in Biotechnology at University of Silesia in Katowice, Poland. She did internship at University of Oxford and University of Southampton, UK. After graduation, she worked at Medical University of Lodz in Poland, where she focused on a genetic background and miRNA role in optic nerve degeneration in glaucoma.

During her PhD at Maastricht University, she investigates the genetic cause of neuropathic pain.

Misra Kaalindi

(recruited by Ospedale San Raffaele, Italy)

Kaalindi was born in Mumbai, India. She is an Oregon State bio-engineering graduate with two master’s degree in biotechnology and bioinformatics from University of Exeter and Bhartiya Vidyapeeth Pune respectively.

She worked as a clinical researcher in DNA diagnostics and screening for two years. She is currently applying advanced bioinformatics approach to identify causative variants in pain-related genes.

Katarzyna Malgorzata Kwiatkowska

(recruited by University of Bologna, Italy)

Katarzyna was born in Poland. She has ba ackground in Biotechnology and Bioinformatics, and she is fascinated with computational way of approaching biological phenomena.

Currently she is an highly motivated Early Stage Researcher at the University of Bologna.

Julie Labau

(recruited by Yale University, USA)

Although born in France, Julie’s work and studies took her across the globe. Now part of the Pain-Net program, at Yale University, her research focuses on assessing voltage-gated sodium channel mutations-underlying mechanisms in chronic pain diseases.

Her goal is to develop therapeutic strategies that will enable more patients to effectively benefit from pain treatments.

Farhad Jahanfar

(recruited by Di.V.Al Toscana, Italy)

Farhad received a Bachelor of Science degree in Pure Chemistry and the Master of Science degree in Clinical Biochemistry. His research project aims to perform high-throughput screening of analgesic compounds targeting ion channels.

He is currently a PhD student in genetics, oncology and clinical medicine at the University of Siena.

Celeste Chidiac

(recruited by Centre Europeen de Recherche en Biologie et Medecine, France)

Celeste is a PhD student in IGBMC, Strasbourg, France, and part of the PAIN-NET program. She is working on the creation of a specific mutation in Nav1.8 Sodium channel (Scn10aG1662S ) in mice model and characterization of pain sensitivity and behavior in these models.

Her aim is to gain as much knowledge as possible and acquire enough expertise to become a valuable researcher.

Yaping Xue

(recruited by Centre Europeen de Recherche en Biologie et Medecine, France)

Yaping obtained her Master degree in Cellular Biology from Fujian Normal University in China. Now, she studies at PHENMOMIN-ICS, Strasbourg University.

Her individual project is to characterize two CRISPR-Cas mouse models of genetically defined pain for Nav1.7 (mutation p.Arg185His) and Nav1.8 (mutation p.Gly1662Ser) sodium channel found in painful neuropathy patients.

Ameer Abu Bakr Rasheed

(recruited by Centre Europeen de Recherche en Biologie et Medecine, France)

Ameer received his bachelor degree in Bio and Brain Engineering, Biological Sciences and completed his master program in Brain Science. Currently he is working as Early Stage Researcher (PAIN-Net Project) at IGBMC, University of Strasbourg, France.

His research objective is to develop and evaluate in vitro and in vivo CRISPR-Cas model of chronic itch and to validate the treatment in mouse models.